Barry A Berkowitz
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$4.6MFederal grants as PI6 awards
4Patents grantedLatest Mar 18, 2025
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
6 awards · $4.6M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 13, 2024 | NIH | SBIR Phase I New target and new therapy for severe Covid-19 and viral hyperinflammation damage: renalase and renalase agonists | $297K | BESSOR PHARMA, LLC |
| Jul 21, 2022 | NIH | SBIR Phase II Novel Target, New Therapy: Anti- Renalase Antibody for Tumors Resistant to PD-1Inhibitors | $672K | BESSOR PHARMA, LLC |
| Aug 12, 2021 | NIH | SBIR Phase II Novel Target, New Therapy: Anti- Renalase Antibody for Tumors Resistant to PD-1Inhibitors | $1.3M | BESSOR PHARMA, LLC |
| Apr 27, 2020 | NIH | SBIR Phase II Renalase: Development as an Innovative New Drug for Acute Pancreatitis | $1.1M | BESSOR PHARMA, LLC |
| May 10, 2019 | NIH | SBIR Phase II Renalase: Development as an Innovative New Drug for Acute Pancreatitis | $849K | BESSOR PHARMA, LLC |
| Sep 20, 2016 | NIH | SBIR Phase I Acute Pancreatitis: Renalase as a novel target and agonists as new therapy | $300K | BESSOR PHARMA, LLC |
5 patents as inventor
- US 11370768BESSOR PHARMA, LLCJun 28, 2022
- US 11407724BESSOR PHARMA, LLCAug 9, 2022
- US 11685724BESSOR PHARMA, LLCJun 27, 2023
- US 12252477BESSOR PHARMA, LLCMar 18, 2025
- US BESSOR PHARMA, LLC—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#312
Awards as PI#315
Patents#41
Companies
- BESSOR PHARMA, LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.